« Previous
Next »
Transplantation Proceedings
Volume 35, Issue 8
, Pages 2878-2880
, December 2003
Triple immunosuppression with or without basiliximab in pediatric renal transplantation: acute rejection rates at one year
References
-
Tejani A, Stablein DM, Donaldson L, et al: Steady improvement in short-term graft survival of pediatric renal transplants: the NAPRTCS experience. Clin Transpl 95, 1999
-
Five-year survival of kidney transplantation in children (data from the European (EDTA-ERA) Registry).
Kidney Int. 1993;44:S22
- Pediatric renal transplantation (Experience from a center in Central Anatolia). Transplant Proc. 2002;33:3597
-
.
Anti-interleukin-2 receptor monoclonal antibodies in renal transplantation.
Nephron Dial Transplant. 1999;14:2824
- Basiliximab induction improves the outcome of renal transplants in children and adolescents. Pediatr Nephrol. 2001;16:693
- Single centre experience with basiliximab in pediatric renal transplantation. Nephrol Dial Transplant. 2002;17:276
- Pediatric renal transplantation under tacrolimus-based immunosuppression. Transplantation. 1999;67:299
PII: S0041-1345(03)01197-7
doi: 10.1016/j.transproceed.2003.10.087
© 2003 Elsevier Science Inc. All rights reserved.
« Previous
Next »
Transplantation Proceedings
Volume 35, Issue 8
, Pages 2878-2880
, December 2003
